108.26
price up icon0.70%   0.75
pre-market  Pre-mercato:  108.14   -0.12   -0.11%
loading

Perché le azioni Biontech Se Adr (BNTX) sono in ribasso?

Abbiamo notato un calo di 5.01% nelle azioni di Biontech Se Adr (BNTX) durante la sessione di negoziazione di 2025-05-30. Sebbene ciò possa essere attribuito alla normale volatilità o a vari fattori interni ed esterni, tieni presente che stiamo monitorando attivamente la situazione e forniremo aggiornamenti tempestivi il prima possibile!
2023-10-16:

Shares of BioNTech Se (BNTX) dropped by 6.38% from $103.58 to $96.97 in the trading on Monday, October 16, 2023. The reasons why BNTX stock down include:

  • Pfizer's sales outlook cut: BioNTech's partner, Pfizer, decided to slash its full-year sales expectations by $9 billion, citing a shift towards the commercial approval of its Paxlovid COVID treatment and other factors. The impact of Pfizer's news rippled through the pharmaceutical sector, causing declines in the shares of BioNTech.
  • Downgrade rating: BioNTech received a downgrade from HSBC research analysts on Monday. They changed their rating from Buy to hold in a research report distributed to clients and investors, as reported by Marketbeat.com. Additionally, they revised their price target for the stock from $124.00 to $111.00. This indicates a more neutral stance on BioNTech's prospects, reflecting a potential shift in market sentiment or the analysts' assessment of the company's current position.
biotechnology ONC
$244.32
price down icon 0.34%
$98.24
price up icon 0.64%
$22.62
price up icon 6.70%
$545.11
price up icon 0.49%
$36.19
price up icon 0.86%
Capitalizzazione:     |  Volume (24 ore):